Real-time enrollment status for this follicular lymphoma clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 2:13 AM UTC
| NCT Number | NCT04224493 |
| Recruiting Status | Recruiting |
| Condition | Follicular Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 612 participants |
| Active Locations | 76 sites in the US |
| Sponsor | Epizyme, Inc. |
| Last Updated on CT.gov | March 2, 2026 (Mar 2, 2026) |
As of April 17, 2026: Clinical trial NCT04224493 is currently recruiting participants. This clinical trial study for follicular lymphoma is actively seeking new participants at 76 locations across the United States. The study is sponsored by Epizyme, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04224493 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 76 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04224493 was last updated Mar 2, 2026 (March 2, 2026). HelloStudys verifies this status automatically.